Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 24.60B | 24.00B | 22.85B | 21.80B | 20.79B |
Gross Profit | 6.72B | 6.59B | 5.99B | 5.57B | 5.26B |
EBITDA | 3.50B | 3.47B | 3.04B | 2.64B | 2.40B |
Net Income | 2.24B | 2.27B | 1.97B | 1.62B | 1.42B |
Balance Sheet | |||||
Total Assets | 25.16B | 23.89B | 21.72B | 19.96B | 18.43B |
Cash, Cash Equivalents and Short-Term Investments | 7.79B | 6.55B | 5.59B | 4.70B | 3.84B |
Total Debt | 1.52B | 1.87B | 1.97B | 2.14B | 2.15B |
Total Liabilities | 6.63B | 6.89B | 6.52B | 6.35B | 6.11B |
Stockholders Equity | 18.53B | 17.00B | 15.15B | 13.59B | 12.30B |
Cash Flow | |||||
Free Cash Flow | 2.28B | 2.06B | 1.75B | 1.66B | 1.68B |
Operating Cash Flow | 2.38B | 2.19B | 1.94B | 1.80B | 1.85B |
Investing Cash Flow | 43.88M | -673.38M | -379.00M | -134.80M | 48.60M |
Financing Cash Flow | -1.14B | -803.57M | -678.10M | -602.21M | -922.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥28.09B | 12.39 | 2.79% | 1.65% | -2.94% | ||
77 Outperform | ¥26.10B | 10.99 | 1.20% | 9.56% | 7.39% | ||
76 Outperform | ¥28.70B | 19.55 | 1.84% | 22.28% | 19.69% | ||
74 Outperform | ¥25.78B | 13.20 | 4.30% | 13.54% | 15.43% | ||
67 Neutral | ¥25.56B | 33.53 | 1.69% | 5.38% | -8.86% | ||
61 Neutral | €6.51B | 18.05 | 3.81% | 2.09% | 2.46% | -30.42% | |
60 Neutral | ¥36.56B | 134.58 | ― | -17.30% | ― |